The Health Risks of Saccharin Revisited
- 1 January 1990
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 20 (5) , 311-326
- https://doi.org/10.3109/10408449009089867
Abstract
Almost from its discovery in 1879, the use of saccharin as an artificial, non-nutritive sweetener has been the center of several controversies regarding potential toxic effects, most recently focusing on the urinary bladder carcinogenicity of sodium saccharin in rats when fed at high doses in two-generation studies. No carcinogenic effect has been observed in mice, hamsters, or monkeys, and numerous epidemiological studies provide no clear or consistent evidence to support the assertion that sodium saccharin increases the risk of bladder cancer in the human population. Mechanism of action studies in the one susceptible species, the rat, continue to provide information useful in assessing potential risk to the human from saccharin consumption. Unlike typical carcinogens which interact with DNA, sodium saccharin is not genotoxic, but leads to an increase in cell proliferation of the urothelium, the only target tissue. It also appears that the effect of saccharin is modified by the salt form in which it is administered, despite equivalent concentrations of saccharin in the urine. The chemical form of saccharin in the urine is unaffected, and there is no evidence for a specific cell receptor for the saccharin molecule. Changes in several urinary parameters, such as pH, sodium, protein, silicates, volume, and others, appear to influence the reaction of the urothelium to sodium saccharin administration. Silicon-containing precipitate and/or crystals appear to be generated in the urine under specific circumstances, acting as microabrasive, cytotoxic material. Using a mathematical model of carcinogenesis, which encompasses the temporal dynamics and complexity of the process at a cellular level, including spontaneous genetic transitions, it has been shown that the effects of sodium saccharin can be explained entirely in terms of its non-genotoxic influence on cell proliferation. In interpreting these analytical studies in the human context, particularly as they pertain to the urinary milieu which appears to be pivotal in the effect of sodium saccharin, we are led to the conclusion that there is a threshold effect in male rats and that an effect on the human urothelium is unlikely at even the highest levels of human consumption.Keywords
This publication has 71 references indexed in Scilit:
- Saccharin: A toxicological and historical perspectivePublished by Elsevier ,2002
- SaccharinDiabetes Care, 1989
- DIETARY FACTORS AND THE INCIDENCE OF CANCER OF THE URINARY BLADDERAmerican Journal of Epidemiology, 1988
- Use of Short-Term Test Data in Risk Analysis of Chemical CarcinogensPublished by Springer Nature ,1988
- A review of epidemiological studies on artificial sweeteners and bladder cancerFood and Chemical Toxicology, 1985
- Non-nutritive sweeteners and bladder cancer.American Journal of Public Health, 1982
- An independent analysis of the National Cancer Institute study on non-nutritive sweeteners and bladder cancer.American Journal of Public Health, 1982
- The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologiesCarcinogenesis: Integrative Cancer Research, 1981
- ARTIFICIAL SWEETENERS AND HUMAN BLADDER CANCERThe Lancet, 1980
- ARTIFICIAL SWEETENERS AND HUMAN BLADDER CANCERThe Lancet, 1977